JANSSEN CILAG FARMACEUTICA, LDA. secures contract for 1246/2024 - Invitation To Submit A Proposal By Direct Award For The Acquisition Of B466 - Bosentano [32 Mg; Comp Disp] B925 - Bedaquiline [100 Mg; Cap/Comp] T1818 - Teclistamab [90 Mg/Ml; 1.7Ml; Sun

Portugal, Nov. 12 -- Portugal based JANSSEN CILAG FARMACEUTICA, LDA. has secured contract from Unidade Local De Saude De Santo Antonio, E. P. E. for 1246/2024 - Invitation To Submit A Proposal By Direct Award For The Acquisition Of B466 - Bosentano [32 Mg; Comp Disp] B925 - Bedaquiline [100 Mg; Cap/Comp] T1818 - Teclistamab [90 Mg/Ml; 1.7Ml; Sun. The value of the contract is worth 3315936 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....